Concepedia

Edwin B. Villhauer

EB

Statistics

Publications

11

Citations

1.1K

H-Index

10

Active since

1984

Affiliations

Novartis (United States)(Current)

Novartis (Switzerland)

Edwin B. Villhauer is an author at Novartis (United States) specializing in medicinal chemistry, drug discovery, and chemistry.

Publications per year

1984–2010

11

Publications

11

1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(<i>S</i>)-pyrrolidine:  A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic Properties

Edwin B. Villhauer, J. A. Brinkman, Goli B. Naderi et al. · Journal of Medicinal Chemistry · 2003 · 613 citations · Full text

, , +12

NVP-DPP728 (1-[[[2-[(5-Cyanopyridin-2-yl)amino]ethyl]amino]acetyl]-2-cyano-(<i>S</i>)-pyrrolidine), a Slow-Binding Inhibitor of Dipeptidyl Peptidase IV

Thomas E. Hughes, Manisha Mone, Mary E. Russell et al. · Biochemistry · 1999 · 126 citations

, , +13

1-[2-[(5-Cyanopyridin-2-yl)amino]ethylamino]acetyl-2-(<i>S</i>)-pyrrolidinecarbonitrile:  A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic Properties

Edwin B. Villhauer, J. A. Brinkman, Goli B. Naderi et al. · Journal of Medicinal Chemistry · 2002 · 120 citations · Full text

, , +12

Conformation of [1-13C,15N]Acetyl-L-carnitine. Rotational-Echo, Double-Resonance Nuclear Magnetic Resonance Spectroscopy

Robert C. Anderson, Terry Gullion, Michael J. Shapiro et al. · Journal of the American Chemical Society · 1995 · 50 citations

, , +10

A Concise Synthesis of a Novel Insulin-Like Growth Factor I Receptor (IGF-IR) Inhibitor

Joel Slade, Joginder S. Bajwa, Hui Liu et al. · Organic Process Research & Development · 2007 · 38 citations

, , +11

1–5 of 11